Clinical Trials

Solid Tumor

NCT06832982 2026-04-09

Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002

Phase 1 Recruiting

66 enrolled

Phase 1/2 Not yet recruiting

Advanced Solid Tumors

NCT07508761 2026-04-02

IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors

52 enrolled

Advanced Solid Tumor

NCT06953323 2026-03-27

A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors

86 enrolled

Phase 2 Not yet recruiting

Advanced Solid Tumor

NCT07480733 2026-03-25

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

480 enrolled

Advanced Malignant Solid Tumors

NCT07392736 2026-02-06

A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.

228 enrolled

Phase 1/2 Active not recruiting

Solid Tumor

NCT05518045 2026-02-04

A Study of LM-108 as Monotherapy or in Combination With Antitumor Therapies in Subjects With Advanced Solid Tumors

392 enrolled

Advanced Solid Tumor

NCT04284488 2026-01-08

Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors

Phase 1/2 Terminated

40 enrolled

Phase 1/2 Not yet recruiting

Advanced Solid Tumor

NCT07245901 2025-11-24

Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors

60 enrolled

Solid Tumor

NCT06682780 2025-09-25

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

320 enrolled

Advanced Solid Tumor

NCT06868199 2025-09-12

A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours

87 enrolled

Advanced Solid Tumours

NCT06088004 2025-08-22

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

218 enrolled

Solid Tumor, Adult

NCT06208410 2025-07-25

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

306 enrolled

Phase 1/2 Active not recruiting

Advanced Solid Tumors

NCT04322006 2025-05-22

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

376 enrolled

Advanced Solid Tumor

NCT04914286 2025-05-14

A Study of GFH018 in Combination With Toripalimab in Patients With Advanced Solid Tumors

148 enrolled

Advanced Solid Tumor

NCT05830539 2025-05-02

IN10018 Combination Therapy in Previously-treated Locally Advanced or Metastatic Solid Tumor Patients

68 enrolled

Phase 2 Not yet recruiting

Locally Advanced or Metastatic Solid Tumors

NCT06873854 2025-03-13

A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours

84 enrolled

Advanced Solid Tumor

NCT05188664 2025-02-17

Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors

20 enrolled

Advanced Solid Tumor

NCT06038396 2025-01-29

A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors

48 enrolled

Advanced Solid Tumor

NCT06139211 2024-12-20

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

186 enrolled

Advanced Solid Tumor

NCT06117566 2024-11-25

A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors

100 enrolled

Solid Tumor

NCT06410703 2024-10-31

CAN1012 Combined With PD-1 in Patients With Solid Tumors

71 enrolled

Advanced Solid Tumor

NCT06490068 2024-07-08

Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy

Phase 2 Recruiting

10 enrolled

Advanced Solid Tumor

NCT03874897 2024-04-30

Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.

Phase 1 Completed

134 enrolled

Phase 2 Active not recruiting

Advanced Solid Tumor

NCT04301557 2024-04-23

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

25 enrolled

GastrointestinalOther solid neoplasm

DMMR Colorectal Cancer

NCT05576961 2024-01-23

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

Phase 1/2 Unknown

60 enrolled

Solid Tumor

NCT04357756 2023-09-13

A Study to Assess YH001 in Combination With Toripalimab Injection in Subjects With Advanced Solid Tumors

Phase 1 Completed

29 enrolled

Advanced Solid Tumor

NCT05699811 2023-04-28

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

40 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT05809336 2023-04-12

Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors

Phase 2/3 Completed

172 enrolled

Advanced Solid Tumor

NCT04169672 2023-03-02

Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors

Phase 2 Completed

248 enrolled

Advanced Solid Tumors

NCT04481009 2022-12-12

A Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumors

26 enrolled

Advanced Solid Tumors

NCT05502393 2022-08-16

A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors

Phase 1 Unknown

118 enrolled

Advanced Solid Tumors

NCT05165849 2022-05-20

A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors

Phase 1/2 Withdrawn

Solid Tumor

NCT05369286 2022-05-11

A Study to Evaluate the Safety and Efficacy of Max-40279 and Toripalimab in Patients With Advanced Solid Tumors

Phase 1 Unknown

28 enrolled

Solid Tumor

NCT04337463 2021-05-17

ATG-008 Combined With Toripalimab in Advanced Solid Tumors

Phase 1/2 Unknown

60 enrolled